พบ "Public health policy"ทั้งหมด 1,302 ผลลัพธ์
A review of the health and economic implications of patent protection, with a specific focus on Thailand (2012)
Inthira Yamabhai1,2* and Richard D Smith2
Abstract
Background: Although it has been two decades since the Thai Patent Act was amended to comply with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), there has been little emphasis given to assessing the implication
A review of economic evaluation studies in Thailand: Are the data good enough to be used in decision making?
นักวิจัย: ภญ.ศิตาพร ยังคง The International Regulation of New Medical Technology: Health Technology Adoption in the European Union, North America, East Asia and in the Developing World
A Retrospective Secondary Data Analysis of Telemedicine Service Utilization (2020-2023) Among Patients Covered By The Universal Coverage Scheme in Thailand
Abstract
Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current
A Retrospective Secondary Data Analysis of Telemedicine Service Utilization (2020-2023) Among Patients Covered By The Universal Coverage Scheme in Thailand
Abstract
Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current
A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance
Abstract
Background
Antimicrobial resistance (AMR) is accelerated by the widespread and often indiscriminate use of antimicrobials in humans, animals, and the environment. In 2015, the World Health Organization recognised AMR as one of the top ten global health threats, due to its potential to n
A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region
Abstract
Background
Progress towards achieving Universal Health Coverage and institutionalizing healthcare priority setting through health technology assessment (HTA) in the Association of South-East Asian Nations (ASEAN) region varies considerably across countries because of differences in heal
A Geneticist’s Research Turns Personal
http://www.nytimes.com/2012/06/03/business/geneticists-research-finds-his-own-diabetes.html?partner=rss&emc=rssHUMAN genome sequencing is already helping researchers find new treatments for illness. Now an unusual case study suggests that the benefits of sequencing may be enhanced in combination
A Difficult Balancing Act: Policy Actors’ Perspectives on Using Economic Evaluation to Inform Health-Care Coverage Decisions under the Universal Health Insurance Coverage Scheme in Thailand. (2008)
A Difficult Balancing Act: Policy Actors’ Perspectives on Using Economic Evaluation to Inform Health-Care Coverage Decisions under the Universal Health Insurance Coverage Scheme in Thailand
Yot Teerawattananon1 Steve Russell2
1Health Intervention and Technology Assessment Program (HITAP), Mini
A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. (2010)
A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand.
Pattara Leelahavarong1,2, Usa Chaikledkaew1,2*, Suradej Hongeng3, Vijj Kasemsup4, Yoel Lubell1,5, Yot Teerawattananon1
1Health Intervention and Technolog
A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand (2014)
Abstract
Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a pharmaceutical reimbursement list in Thailand. There have also been no economic evaluation studies of CHB drug treatments conducted in Thailand yet. I
10 / หน้า